⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT March 23, 2026

Buprenorphin ratiopharm 5 Mikrogramm/h transdermales Pflaster 5 Mikrogramm/h (transdermales Pflaster)

📷 Wikipedia: Buprenorphine · Source
Buprenorphin ratiopharm 5 Mikrogramm/h transdermales Pflaster 5 Mikrogramm/h (transdermales Pflaster)
📷 Wikipedia: Buprenorphine · Source
Buprenorphin ratiopharm 5 micrograms/h transdermal patch is subject to a parallel export ban.
⚠️
Shortage ongoing
BUPRENORPHIN is currently in short supply in AT.
📈 Timeline
117 days active so far
May 18, 2026 September 11, 2026

What is this? This is a small patch that sticks to your skin. It gives medicine called buprenorphine to help with pain.

What's happening? Some boxes with 4 patches are hard to find right now. Boxes with 2 patches are still available.

Does this affect me? If you use this patch, check if you have the 4-patch box. If you do, you may need a new supply.

What should I do? Ask your pharmacist or doctor for help finding the right amount. Do not stop using your medicine without talking to them first.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
BUPRENORPHIN
Agency-published detail

🚫 Parallel export ban active · ATC: N02AE01 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 4 Stück Schachtel, Beutel [Nicht verfügbar, since 2026-03-22] · 2 Stück Schachtel, Beutel [Nicht verfügbar, since 2026-06-15]

First published
March 23, 2026
Last refreshed by us
2 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 3 months ago

Buprenorphin ratiopharm 20 Mikrogramm/h transdermales Pflaster 20 Mikrogramm/h (transdermales Pflaster)

Parallel export ban in effect for Buprenorphin ratiopharm 20 microgram/h transdermal patch.
High AT 4 months ago

Buprenorphin ratiopharm 10 Mikrogramm/h transdermales Pflaster 10 Mikrogramm/h (transdermales Pflaster)

Parallel export ban in effect. Supply delayed due to manufacturing issues.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Buprenorphin ratiopharm 5 Mikrogramm/h transdermales Pflaster 5 Mikrogramm/h (transdermales Pflaster). Buprenorphin ratiopharm 5 micrograms/h transdermal patch is subject to a parallel export ban.
▸ When was this alert issued?
This alert was issued on March 23, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.